A novel semisynthetic glycopeptide antibiotics
CAS：171099-57-3
分子式：C6H97Cl3N10O26
分子量：1793.12
纯度：98%
存储：Store at -20°C

Background:

Oritavancin is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram-positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci.